Search

COVID19 Places: India

covid-19_slides_0_1.png

This essay scaffolds a discussion of how COVID19 is unfolding in India. A central question this essay hopes to build towards is: If we examine the ways COVID19 is unfolding in India, does "Ind

Class Inequalities, Government Response, Citizen Initiatives

Nishtha
Annotation of
In response to

Covid-19 and class inequalities :

As India Battles Covid, Class Divide is Growing https://www.deccanchronicle.com/opinion/columnists/070520/sanjay-kumar-as-india-battles-covid-class-divide-is-growing.html

 A Pandemic in an Unequal India https://www.thehindu.com/opinion/op-ed/a-pandemic-in-an-unequal-india/article31221919.ece

 India cannot Fight Coronavirus without Taking into Account its Class and Caste Divisions https://scroll.in/article/956980/india-cannot-fight-coronavirus-without-taking-into-account-its-class-and-caste-divisions

The Lockdown Revealed the Extent of Poverty and Misery Faced by Migrant Workers https://thewire.in/labour/covid-19-poverty-migrant-workers

India's Response to COVID-19 Is a Humanitarian Disaster http://bostonreview.net/global-justice/debraj-ray-s-subramanian-indias-r...

Documentation of Disaster Relief Work :

PM-CARES Fund 'Not a Public Authority', Doesn't Fall Under RTI Act: PMO https://thewire.in/government/pm-cares-fund-not-a-public-authority-rti-act-pmo

 Community volunteers:  

https://www.facebook.com/thejucommune/

pece_annotation_1473449061

tamar.rogoszinski
Annotation of
In response to
    1. “…large­-scale social forces—racism, gender inequality, poverty, political violence and war, and sometimes the very policies that address them—often determine who falls ill and who has access to care.”
    2. "the holy grail of modern medicine remains the search for the molecular basis of disease."
    3. "In some senses, the model is simple: clinical and community barriers to care are removed as diagnosis and treatment are declared a public good and made available free of charge to patients living in poverty."
    4. "The poor are the natural constituents of public health, and physicians ... are the natural attourneys of the poor."

     

     

    pece_annotation_1473995548

    tamar.rogoszinski
    Annotation of
    In response to
    1. I first looked up travel to and from Liberia during the Ebola outbreak, since it had been seized. There was a ban, which has since been lifted after, but people coming to and from West Africa are still screened and recommended to visit physicians. As of mid-2015 there wa still a 21 day monitoring period needed. http://www.infectioncontroltoday.com/news/2015/05/cdc-downgrades-travel…'
    2. I was interested if there had been any progress on treatment for Ebola, but found that the main form of treatment is supportive care. Doctors are informed to provide IV fluid and ensure that the patient's immune response and other bodily functions are functioning properly. A vaccine is being worked on but has not gone through a trial to prove safety and effectiveness. https://www.cdc.gov/vhf/ebola/treatment/index.html
    3. I looked further into the vaccine being produced for Ebola. Currently, there is a combined phase 2 and phase 3 trial occurring in Sierra Leone called STRIVE (Sierra Leone Trial to Introduce a Vaccine against Ebola). The study is unblinded, so patients know whether or not they have received the vaccine. The vaccine is a rVSV-ZEBOV, or recombinant Vesicular Stomatitis Virus Zaire ebolavirus vaccine. This vaccine is also being used in phase 2 and phase 3 trials in Guinea and Liberia http://www.cdc.gov/vhf/ebola/strive/qa.html

    pece_annotation_1475202196

    tamar.rogoszinski
    Annotation of
    In response to

    The convention in 1951 was a response to WW2 and the vast amounts of refugees that existed as a result. States involved in the convention and the UN could decide to apply it to refugees not necessarily from WW2, but in 1967, the limits were removed and made it so that it could apply to any refugees, not just those from WW2. It has since been used during major refugee crises in Africa, the Middle East, and Asia.